Tag: HY-091
AFT Pharmaceuticals spearheads progress in women’s health with Hyloris partnership
AFT Pharmaceuticals announced its partnership with Hyloris Pharmaceuticals, based in Belgium, to develop a novel treatment, HY-091, for Vulvar Lichen Sclerosus (VLS), addressing the critical need for effective solutions in an area where approved treatments are limited.
Featured Article
Australian Manufacturing Week 2026 to make Brisbane debut
Australia’s leading advanced manufacturing showcase, Australian Manufacturing Week (AMW), is set to return in 2026, marking its first-ever event in Brisbane.
